Cargando…

No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case–control study

Melanoma is one of the most aggressive human cancers. The vitamin D system contributes to the pathogenesis and prognosis of malignancies including cutaneous melanoma. An expression of the vitamin D receptor (VDR) and an anti-proliferative effect of vitamin D in melanocytes and melanoma cells have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schäfer, Annika, Emmert, Steffen, Kruppa, Jochen, Schubert, Steffen, Tzvetkov, Mladen, Mössner, Rotraut, Reich, Kristian, Berking, Carola, Volkenandt, Matthias, Pföhler, Claudia, Schön, Michael P., Vogt, Thomas, König, Inke R., Reichrath, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382284/ https://www.ncbi.nlm.nih.gov/pubmed/22576141 http://dx.doi.org/10.1007/s00403-012-1243-3

Ejemplares similares

Analysis of a functional serotonin transporter promoter polymorphism in psoriasis vulgaris
por: Mössner, Rotraut, et al.
Publicado: (2008)

Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis
por: Reichrath, Jörg, et al.
Publicado: (2022)

The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives
por: Reichrath, Jörg, et al.
Publicado: (2013)

Low Serum 25-Hydroxyvitamin D Concentrations Are Associated with Increased Risk for Melanoma and Unfavourable Prognosis
por: Bade, Benjamin, et al.
Publicado: (2014)

Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
por: Vlahova, Lyubomira, et al.
Publicado: (2021)

Do not underestimate nucleotide excision repair: It not only predicts melanoma risk but also survival outcome
por: Emmert, Steffen, et al.
Publicado: (2013)

The Prognostic and Predictive Role of Xeroderma Pigmentosum Gene Expression in Melanoma
por: Fischer, Sarah, et al.
Publicado: (2022)

Risk estimation and risk prediction using machine-learning methods
por: Kruppa, Jochen, et al.
Publicado: (2012)

Sneaky side effects and ineffectiveness of an immunotherapy with ipilimumab in a case of metastatic melanoma
por: Krecké, Nathalie, et al.
Publicado: (2016)

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases
por: Mössner, Rotraut, et al.
Publicado: (2008)

Transcriptional Profiling of Human Endogenous Retrovirus Group HERV-K(HML-2) Loci in Melanoma
por: Schmitt, Katja, et al.
Publicado: (2013)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Exploring the Most Visible German Websites on Melanoma Immunotherapy: A Web-Based Analysis
por: Brütting, Julia, et al.
Publicado: (2018)

How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
por: Wessely, Anja, et al.
Publicado: (2021)

Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma
por: Satzger, Imke, et al.
Publicado: (2015)

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study
por: Tietze, Julia K., et al.
Publicado: (2018)

High-throughput miRNA profiling of human melanoma blood samples
por: Leidinger, Petra, et al.
Publicado: (2010)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
por: Heppt, Markus V., et al.
Publicado: (2019)

Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997)

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
por: Heppt, Markus V., et al.
Publicado: (2017)

Clonality of CD4(+) Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
por: Arakawa, Akiko, et al.
Publicado: (2019)

Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1
por: Senft, Daniela, et al.
Publicado: (2012)

Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
por: Koch, Elias A. T., et al.
Publicado: (2023)

Challenge and promise: the role of miRNA for pathogenesis and progression of malignant melanoma
por: Essa, Salma, et al.
Publicado: (2010)

The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review
por: Hornung, Annkathrin, et al.
Publicado: (2021)

Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling
por: Reichrath, Jörg, et al.
Publicado: (2014)

Targeting the non-neuronal cholinergic system in macrophages for the management of infectious diseases and cancer: challenge and promise
por: Reichrath, Sandra, et al.
Publicado: (2016)

Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
por: Koch, Elias A. T., et al.
Publicado: (2023)

Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment
por: Wolk, Kerstin, et al.
Publicado: (2023)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Introducing MARCo: Histoserological Findings of a Multi-Organic Paraneoplastic Syndrome in Cutaneous Melanoma Patients
por: Ranjbar, Mahdy, et al.
Publicado: (2016)

Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells
por: Banicka, Veronika, et al.
Publicado: (2022)

A Critical Appraisal of Strategies to Optimize Vitamin D Status in Germany, a Population with a Western Diet
por: Saternus, Roman, et al.
Publicado: (2019)

The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
por: Steeb, Theresa, et al.
Publicado: (2020)

Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
por: Gandhirajan, Rajesh Kumar, et al.
Publicado: (2018)

A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging
por: Brunner, Georg, et al.
Publicado: (2018)

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
por: Mohr, Peter, et al.
Publicado: (2022)

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
por: Amaral, Teresa, et al.
Publicado: (2020)

Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies
por: Kaiser, Isabelle, et al.
Publicado: (2022)

A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells
por: Wendt, Franziska, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ouer4vvb3d8afgvu8sj53etrq2